The use of polymer-based nanoparticles and nanostructured materials in treatment and diagnosis of cardiovascular diseases: Recent advances and emerging designs

Yen Jen Wang; Mikael Larsson; Wei Ting Huang; Shih Hwa Chiou; Stephen J. Nicholls; Jui I. Chao; Dean Mo Liu

doi:10.1016/j.progpolymsci.2016.01.002

The use of polymer-based nanoparticles and nanostructured materials in treatment and diagnosis of cardiovascular diseases: Recent advances and emerging designs

Yen Jen Wang, Mikael Larsson, Wei Ting Huang, Shih Hwa Chiou, Stephen J. Nicholls, Jui I. Chao, Dean Mo Liu

Research output: Contribution to journal › Review Article › Research › peer-review

56 Citations (Scopus)

Abstract

This review summarizes important advances in polymer-based nanotechnologies for the treatment and diagnosis of cardiovascular diseases, focusing on nanoparticles and nanostructured materials/devices. The current state of the art and design parameters are discussed with the aim of providing a source of information that can aid in the development of new treatments by bridging between materials development, preclinical, and clinical trials. This is highly relevant as cardiovascular diseases remain a leading cause of death worldwide and as current treatments burden the healthcare systems with great costs. Different strategies, from targeting theranostic nanocarriers, to dual-drug depot systems, injectable cell scaffolds, and LDL acceptors are treated. The review ends with a concluding outlook on the possibilities and challenges presented to polymer-based nanotechnologies in cardiovascular disease therapy.

Original language	English
Pages (from-to)	153-178
Number of pages	26
Journal	Progress in Polymer Science
Volume	57
DOIs	https://doi.org/10.1016/j.progpolymsci.2016.01.002
Publication status	Published - 1 Jun 2016
Externally published	Yes

Keywords

Cardiovascular diseases
Drug delivery
Nanoparticles
Nanostructured
Polymers
Theranostic

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.progpolymsci.2016.01.002

Cite this

@article{74c2003787f34be79b6f2f0cd6a17d9e,

title = "The use of polymer-based nanoparticles and nanostructured materials in treatment and diagnosis of cardiovascular diseases: Recent advances and emerging designs",

abstract = "This review summarizes important advances in polymer-based nanotechnologies for the treatment and diagnosis of cardiovascular diseases, focusing on nanoparticles and nanostructured materials/devices. The current state of the art and design parameters are discussed with the aim of providing a source of information that can aid in the development of new treatments by bridging between materials development, preclinical, and clinical trials. This is highly relevant as cardiovascular diseases remain a leading cause of death worldwide and as current treatments burden the healthcare systems with great costs. Different strategies, from targeting theranostic nanocarriers, to dual-drug depot systems, injectable cell scaffolds, and LDL acceptors are treated. The review ends with a concluding outlook on the possibilities and challenges presented to polymer-based nanotechnologies in cardiovascular disease therapy.",

keywords = "Cardiovascular diseases, Drug delivery, Nanoparticles, Nanostructured, Polymers, Theranostic",

author = "Wang, {Yen Jen} and Mikael Larsson and Huang, {Wei Ting} and Chiou, {Shih Hwa} and Nicholls, {Stephen J.} and Chao, {Jui I.} and Liu, {Dean Mo}",

year = "2016",

month = jun,

day = "1",

doi = "10.1016/j.progpolymsci.2016.01.002",

language = "English",

volume = "57",

pages = "153--178",

journal = "Progress in Polymer Science",

issn = "0079-6700",

publisher = "Elsevier",

}

The use of polymer-based nanoparticles and nanostructured materials in treatment and diagnosis of cardiovascular diseases: Recent advances and emerging designs. / Wang, Yen Jen; Larsson, Mikael; Huang, Wei Ting et al.
In: Progress in Polymer Science, Vol. 57, 01.06.2016, p. 153-178.

Research output: Contribution to journal › Review Article › Research › peer-review

TY - JOUR

T1 - The use of polymer-based nanoparticles and nanostructured materials in treatment and diagnosis of cardiovascular diseases

T2 - Recent advances and emerging designs

AU - Wang, Yen Jen

AU - Larsson, Mikael

AU - Huang, Wei Ting

AU - Chiou, Shih Hwa

AU - Nicholls, Stephen J.

AU - Chao, Jui I.

AU - Liu, Dean Mo

PY - 2016/6/1

Y1 - 2016/6/1

N2 - This review summarizes important advances in polymer-based nanotechnologies for the treatment and diagnosis of cardiovascular diseases, focusing on nanoparticles and nanostructured materials/devices. The current state of the art and design parameters are discussed with the aim of providing a source of information that can aid in the development of new treatments by bridging between materials development, preclinical, and clinical trials. This is highly relevant as cardiovascular diseases remain a leading cause of death worldwide and as current treatments burden the healthcare systems with great costs. Different strategies, from targeting theranostic nanocarriers, to dual-drug depot systems, injectable cell scaffolds, and LDL acceptors are treated. The review ends with a concluding outlook on the possibilities and challenges presented to polymer-based nanotechnologies in cardiovascular disease therapy.

AB - This review summarizes important advances in polymer-based nanotechnologies for the treatment and diagnosis of cardiovascular diseases, focusing on nanoparticles and nanostructured materials/devices. The current state of the art and design parameters are discussed with the aim of providing a source of information that can aid in the development of new treatments by bridging between materials development, preclinical, and clinical trials. This is highly relevant as cardiovascular diseases remain a leading cause of death worldwide and as current treatments burden the healthcare systems with great costs. Different strategies, from targeting theranostic nanocarriers, to dual-drug depot systems, injectable cell scaffolds, and LDL acceptors are treated. The review ends with a concluding outlook on the possibilities and challenges presented to polymer-based nanotechnologies in cardiovascular disease therapy.

KW - Cardiovascular diseases

KW - Drug delivery

KW - Nanoparticles

KW - Nanostructured

KW - Polymers

KW - Theranostic

UR - http://www.scopus.com/inward/record.url?scp=84959914954&partnerID=8YFLogxK

U2 - 10.1016/j.progpolymsci.2016.01.002

DO - 10.1016/j.progpolymsci.2016.01.002

M3 - Review Article

AN - SCOPUS:84959914954

SN - 0079-6700

VL - 57

SP - 153

EP - 178

JO - Progress in Polymer Science

JF - Progress in Polymer Science

ER -

The use of polymer-based nanoparticles and nanostructured materials in treatment and diagnosis of cardiovascular diseases: Recent advances and emerging designs

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Cite this